Early cost-effectiveness of tumor infiltrating lymphocytes (TIL) for second line treatment in advanced melanoma: a model-based economic evaluation
暂无分享,去创建一个
W. V. van Harten | J. Haanen | V. Retèl | J. Mewes | L. Steuten | M. G. Geukes Foppen | M. Lindenberg